Related Experiment Video
Updated: Aug 16, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells
Published on: November 21, 2025
Mechanistic Insights into Aldose Reductase-Dependent Modulation of Hypoxia-Inducible Factor-1α in Promoting Renal
Wenke Zhao1, Haoyu Wang1, Jingjing Yan1
1Department of Pharmacology, Wannan Medical University, Wuhu, 241002, China.
Abstract:
Renal fibrosis (RF) represents the common pathological endpoint of all chronic kidney diseases. According to recent evidence, impaired mitophagy, which facilitates epithelial-mesenchymal transition (EMT) in renal tubular epithelial cells (RTECs), substantially contributes to RF progression, although the underlying mechanisms remain unclear. We previously demonstrated that mitophagy mediated by aldose reductase (AR) promotes EMT of hepatocytes. Further investigations are warranted to elucidate whether AR affects RF and EMT in RTECs through the regulation of impaired mitophagy. In the in vivo study, AR knockout remarkably reduced Phosphoinositide 3-kinase (PI3K) and serine/threonine kinase (AKT) phosphorylation and attenuated hypoxia-inducible factor-1α (HIF-1α) expression, while increasing Pink1 and Parkin expression in unilateral ureteral obstruction (UUO)-exposed renal tissues. These changes were linked with a higher expression ratio of microtubule-associated protein 1 light chain 3 (LC3) II/I; low p62 expression; decreased Snail, α-smooth muscle actin (α-SMA), and vimentin expression; enhanced E-cadherin expression; and a reduction in mitochondrial damage, which collectively contributed to mitigate RF. In the in vitro study, knockdown of AR through siRNA or pharmacological inhibition markedly reduced transforming growth factor-beta 1 (TGF-β1)-induced HIF-1α expression, inhibited PI3K/AKT pathway activation, restored mitochondrial autophagy function, decreased levels of reactive oxygen species (ROS) and mitochondrial permeability transition pore (MPTP) opening, and increased mitochondrial membrane potential (ΔΨm) and adenosine triphosphate (ATP) production, thereby reversing EMT in RTECs. Conversely, AR overexpression exacerbated TGF-β1-induced HIF-1α expression, enhanced PI3K/AKT pathway activation, lowered efficiency of mitophagy, increased MPTP opening and ROS levels, reduced ΔΨm and ATP production, and promoted EMT. These findings highlight AR's role as a facilitator of EMT in RTECs and emphasize its critical contribution to RF progression. This process may be mediated by AR-induced expression of HIF-1α, which stimulates the PI3K/AKT signaling pathway, leading to inhibition of Pink1 and Parkin expression, ultimately decreasing mitophagy occurrence in RTECs.
Insights
Aldose reductase (AR) drives renal fibrosis (RF) by impairing mitophagy, promoting epithelial-mesenchymal transition (EMT) in kidney cells. Inhibiting AR restores mitophagy and reverses EMT, offering a potential therapeutic target for chronic kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Renal fibrosis (RF) is the common endpoint of chronic kidney diseases.
- Impaired mitophagy contributes to RF by promoting epithelial-mesenchymal transition (EMT) in renal tubular epithelial cells (RTECs).
- Aldose reductase (AR) was previously shown to mediate mitophagy and promote EMT in hepatocytes.
Purpose of the Study:
- To investigate the role of AR in RF and EMT in RTECs.
- To elucidate the mechanisms by which AR affects mitophagy and EMT in RTECs.
Main Methods:
- In vivo study using AR knockout in a unilateral ureteral obstruction (UUO) mouse model.
- In vitro study involving AR knockdown or overexpression in RTECs treated with transforming growth factor-beta 1 (TGF-β1).
- Analysis of key proteins involved in mitophagy (Pink1, Parkin, LC3, p62), EMT (Snail, α-SMA, vimentin, E-cadherin), signaling pathways (PI3K/AKT, HIF-1α), and mitochondrial function (ROS, MPTP, ΔΨm, ATP).
Main Results:
- AR knockout mitigated RF by reducing PI3K/AKT phosphorylation, decreasing HIF-1α, increasing Pink1/Parkin, enhancing mitophagy, reducing EMT markers, and preserving mitochondrial integrity.
- AR knockdown reversed TGF-β1-induced EMT by inhibiting HIF-1α, PI3K/AKT pathway, and MPTP opening, while restoring mitophagy and mitochondrial function.
- AR overexpression exacerbated TGF-β1-induced EMT by promoting HIF-1α, PI3K/AKT pathway, and MPTP opening, while impairing mitophagy and mitochondrial function.
Conclusions:
- AR facilitates EMT in RTECs and contributes to RF progression.
- AR-induced HIF-1α expression stimulates the PI3K/AKT pathway, inhibiting Pink1/Parkin and decreasing mitophagy.
- Targeting AR may be a potential therapeutic strategy for mitigating RF and associated EMT.
More Related Videos
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

